Organigram Q3,2020 Earnings are out, and Analysts are dissapointed
Organigram Inc. released their third quarter fiscal 2020 earnings with massive cost of sales, causing shares to trade lower pre…
Organigram Inc. released their third quarter fiscal 2020 earnings with massive cost of sales, causing shares to trade lower pre…
Canadian cannabis stocks remain a bad place to put your money. Understand the industry’s problems in this report.
A weekly review of only the most important cannabis news to impact your portfolio
Aurora Cannabis is increasing the share count by 26%. Investors should expect a lower stock price from here as the…
Grizzle reviews the latest earnings results of Aphria, Organigram and Valens. Also they examine the impact of the reverse 12…
A reverse stock split does nothing to fix this company’s long simmering problems. Investors should be prepared for what comes…
A weekly review of only the most important cannabis news to impact your portfolio
A weekly review of only the most important cannabis news to impact your portfolio
Using the power of YCharts, Grizzle identifies some of the cannabis stocks most at risk of going bust.
After the coronavirus market carnage Grizzle examines the value case for investing in Trulieve and whether cannabis drinks are a…